Peptide compliance resources

Practical guidance with the sources attached.

01 / RUO & claim discipline

What FDA and FTC actually look at

Intended use, net impression, and why a research-use-only line does not decide either one.

5 guides
GuideSources verified Sep 3, 2026

Is a “research use only” disclaimer enough for a peptide website?

What FDA and FTC actually look at on a peptide storefront, why a research-use-only line does not decide intended use, and which parts of the site get cited.

Read the guide
GuideSources verified Sep 3, 2026

What did FDA actually say in the Gram Peptides warning letter, and why does it matter for my storefront?

A section-by-section walk through FDA’s March 2026 letter to Gram Peptides: what was reviewed, which claims were quoted, and why the RUO label did not control.

Read the guide
GuideSources verified Sep 3, 2026

What did FDA actually cite in the Xcel Research warning letter, and does “research subjects” wording change anything?

A section-by-section walk through FDA’s December 2024 letter to Xcel Research: what was reviewed, which claims were quoted, and why “test subjects” didn’t help.

Read the guide
GuideSources verified Sep 3, 2026

What did FDA actually say in the USApeptide.com warning letter, and why does it matter for my storefront?

A section-by-section read of FDA’s February 2025 letter to USApeptide.com: four disclaimers set aside, brand-name comparisons, and stacked misbranding theories.

Read the guide
GuideSources verified Sep 3, 2026

What counts as an implied health claim on a peptide website?

What the FTC counts as an implied health claim on a peptide storefront: net impression, disclosures, substantiation, testimonials, and how FTC differs from FDA.

Read the guide
Next in review

Product names that read as health claims: a working list of patterns

Testimonials, before/after photos, and dosage language: what reviewers flag

02 / Peptide payment processing

Why the vertical is treated as high risk

Category codes, restricted-business policies, fund holds, and what a provider can and cannot be shown.

In review
Next in review

Why peptide businesses get called “high risk” (it’s not chargebacks)

Why Stripe, PayPal and Square freeze peptide store funds

03 / Platform & processor policies

What each processor's own text says

Stripe, WooPayments, Shopify Payments, PayPal, Square, and Authorize.net, quoted and dated.

In review
Next in review

Stripe’s restricted businesses policy for peptides, line by line

WooCommerce (WooPayments) and peptides: what’s actually banned

04 / Storefront fixes

What a reviewer checks, and how to fix it

Checklists for names, disclaimers, bundles, testimonials, buyer controls, and evidence packages.

In review
Next in review

The peptide storefront compliance checklist

Where to put your RUO disclaimer (and where it doesn’t help)

Transparency pages

Inspect the method behind the guides

The same discipline the guides follow applies to the product: what was examined, how, and against which sources.